Capital Impact Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-26,554
| Closed | -$594K | – | 29 |
|
|
2024
Q2 | $594K | Sell |
26,554
-5,439
| -17% | -$122K | 1.67% | 38 |
|
|
2024
Q1 | $880K | Buy |
31,993
+5,865
| +22% | +$161K | 1.14% | 35 |
|
|
2023
Q4 | $797K | Buy |
26,128
+14,750
| +130% | +$450K | 1.05% | 47 |
|
|
2023
Q3 | $360K | Hold |
11,378
| – | – | 0.6% | 74 |
|
|
2023
Q2 | $464K | Buy |
11,378
+673
| +6% | +$27.4K | 0.51% | 97 |
|
|
2023
Q1 | $399K | Hold |
10,705
| – | – | 0.49% | 93 |
|
|
2022
Q4 | $373K | Sell |
10,705
-1,249
| -10% | -$43.6K | 0.36% | 119 |
|
|
2022
Q3 | $586K | Buy |
11,954
+464
| +4% | +$22.7K | 0.58% | 52 |
|
|
2022
Q2 | $595K | Buy |
11,490
+3,290
| +40% | +$170K | 0.55% | 69 |
|
|
2022
Q1 | $596K | Buy |
8,200
+3,338
| +69% | +$243K | 0.43% | 116 |
|
|
2021
Q4 | $575K | Sell |
4,862
-2,638
| -35% | -$312K | 0.4% | 77 |
|
|
2021
Q3 | $1.01M | Buy |
+7,500
| New | +$1.01M | 0.4% | 100 |
|
|
2021
Q2 | – | Sell |
-4,468
| Closed | -$359K | – | 134 |
|
|
2021
Q1 | $359K | Sell |
4,468
-215,532
| -98% | -$17.3M | 0.13% | 102 |
|
|
2020
Q4 | $12M | Buy |
220,000
+110,000
| +100% | +$5.98M | 2.94% | 2 |
|
|
2020
Q3 | $2.19M | Buy |
+110,000
| New | +$2.19M | 0.65% | 72 |
|